Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 11.16% | 31.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.16% | 31.49% | |||
| Cost of Revenue | 11.42% | 38.60% | |||
| Gross Profit | 9.38% | -3.51% | |||
| SG&A Expenses | 1.44% | -6.04% | |||
| Depreciation & Amortization | -0.34% | 0.05% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.01% | 30.58% | |||
| Operating Income | 76.60% | 14.01% | |||
| Income Before Tax | 12.48% | 0.28% | |||
| Income Tax Expenses | -58.82% | 198.35% | |||
| Earnings from Continuing Operations | 16.92% | -6.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.92% | -6.50% | |||
| EBIT | 76.60% | 14.01% | |||
| EBITDA | 93.69% | 25.47% | |||
| EPS Basic | 17.30% | -5.88% | |||
| Normalized Basic EPS | 26.56% | 2.34% | |||
| EPS Diluted | 17.30% | -5.88% | |||
| Normalized Diluted EPS | 26.56% | 2.34% | |||
| Average Basic Shares Outstanding | 0.47% | 0.57% | |||
| Average Diluted Shares Outstanding | 0.47% | 0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||